Novel penta-1,4-diene-3-one derivatives containing quinazoline and oxime ether fragments: Design, synthesis and bioactivity.
Novel penta-1,4-diene-3-one derivatives containing quinazoline and oxime ether fragments: Design, synthesis and bioactivity.
复制标题
DOI:
10.1016/j.bmc.2021.115999
复制
发表时间:
2021-01
影响因子:
3.5
通讯作者:
Shijun Su;Meihang Chen;Qin Li;Yihui Wang;Shuai Chen;Nan Sun;C. Xie;Z. Huai;Yinjiu Huang;Wei Xue
中科院分区:
文献类型:
--
作者:
Shijun Su;Meihang Chen;Qin Li;Yihui Wang;Shuai Chen;Nan Sun;C. Xie;Z. Huai;Yinjiu Huang;Wei Xue
A series of novel penta-1,4-diene-3-one derivatives containing quinazoline and oxime ether moieties were designed and synthesized. Their anticancer activities were evaluated by MTT assay, the results showed that most compounds exhibited extremely inhibitory effects against hepatoma SMMC-7721 cells. In particular, compoundsQ2andQ8displayed the more potent inhibitory activity with IC50values of 0.64 and 0.63 μM, which were better than that of gemcitabine (1.40 μM). Further mechanism studies indicated that compoundsQ2,Q8,Q13andQ19could control the migration of SMMC-7721 cells effectively, and inhibit the proliferation of cancer cells by inhibiting the DNA replication. Western-blot results showed that compoundsQ2andQ8induced irreversible apoptosis of SMMC-7721 cells by regulating the expression level of apoptose-related proteins. Those studies demonstrated that the penta-1,4-diene-3-one derivatives containing quinazoline and oxime ether fragments merited further research as potential anticancer agents.